Bristol-Myers Squibb
Trade Bristol-Myers Squibb 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About BMY
Bristol Myers Squibb Co. engages in the discovery, development, licensing, manufacture, marketing, distribution, and sale of biopharmaceutical products. It offers small molecules, products produced from biological processes called biologics, and chimeric antigen receptor (CAR-T) cell therapies.
BMY Key Statistics
Stock Snapshot
As of today, Bristol-Myers Squibb(BMY) shares are valued at $54.57. The company's market cap stands at 111.8B, with a P/E ratio of 18.40 and a dividend yield of 4.6%.
As of 2026-01-22, Bristol-Myers Squibb(BMY) stock has fluctuated between $54.36 and $55.52. The current price stands at $54.57, placing the stock +0.4% above today's low and -1.7% off the high.
The Bristol-Myers Squibb(BMY)'s current trading volume is 12.28M, compared to an average daily volume of 12.81M.
In the last year, Bristol-Myers Squibb(BMY) shares hit a 52-week high of $63.33 and a 52-week low of $42.52.
In the last year, Bristol-Myers Squibb(BMY) shares hit a 52-week high of $63.33 and a 52-week low of $42.52.
BMY News
Janux Therapeutics (JANX) announced a collaboration and exclusive worldwide license agreement with Bristol Myers (BMY). Under the terms of the agreement, the co...
Advertisement Why Bristol-Myers Squibb (BMY) is back on investors’ radar Bristol-Myers Squibb (BMY) just announced a partnership with Microsoft that uses FDA...
Bristol-Myers Squibb Company (BMY) announced an update on their ongoing clinical study. Claim 50% Off TipRanks Premium Study Overview: Bristol-Myers Squibb is...
Analyst ratings
60%
of 30 ratingsMore BMY News
Bristol-Myers Squibb (BMY) stock slipped on Tuesday despite news of an artificial intelligence (AI) agreement with tech giant Microsoft (MSFT). This deal will h...